P ercutaneous mitral commissurotomy (PMC) is the reference treatment for mitral stenosis (MS) in patients with favorable valvular anatomy.1,2 Valve calcification is a known predictor of poor results after PMC in both the immediate and long term. [3][4][5][6][7][8] Specific series have shown the feasibility of PMC in patients with calcified valves, but follow-up was most often limited to midterm. [9][10][11] The only study reporting >10-year follow-up analyzed only commissural calcification. 12 Whether patients with calcified valves should be candidates for PMC or be referred for surgery as first-line treatment is still a debated issue. This is of particular importance in Western countries where valve calcification is frequently encountered in rheumatic MS.
13-15The aim of this study is, therefore, to analyze clinical results of PMC according to the presence and extent of valve calcification, with a particular emphasis on long-term results.
Methods
Study PopulationThe population consisted of 1024 consecutive patients, residing in France, who underwent PMC for rheumatic MS between 1986 and 1995 in our institution. Patients presenting with degenerative calcific MS because of annular and leaflet calcification without commissural fusion were not considered for PMC. To assess the relationship between the presence of valve calcification, as defined by fluoroscopy, and outcome, the overall population was split into calcified and noncalcified groups. Of this cohort, 314 (31%) had valve calcification, whereas 710 patients (69%) had noncalcified valves. Previous cerebral or peripheral embolic event occurred in 119 patients (19%), a mean of 3 years before PMC. The study was approved by the local review committee. Patients gave written informed consent before PMC.
MeasurementsEchocardiographic examination was performed on the day preceding PMC and 24 to 48 hours after the procedure by the same experienced Background-Indications of percutaneous mitral commissurotomy (PMC) remain debated in calcific mitral stenosis. We analyzed long-term results of PMC for calcific mitral stenosis and the factors associated with late functional results. Methods and Results-We compared the characteristics and outcome of 314 patients undergoing PMC for calcific mitral stenosis with 710 patients with noncalcified valves followed up to 20 years. Calcification was defined by fluoroscopy, and its extent was graded from 1 to 4. Good immediate results (valve area ≥1.5 cm 2 with mitral regurgitation ≤2/4) were obtained in 251 patients (80%) with calcified valves and 661 (93%) with noncalcified valves (P<0.001). The hazard ratio for good functional results (survival without cardiovascular death, without mitral reintervention, and in New York Heart Association class I or II) was 2.5 (95% confidence interval [2.1-2.9]; P<0.0001) in patients with calcified valves (12±3% at 20 years) relative to the noncalcified group (38±2% at 20 years). In the 251 patients with calcified valves who had good immediate results, 15-year rates of good functional results were ...